English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Various methods have been described in the literature for the treatment of painful end neuromas. One technique involves capping the neuroma with a biological or synthetic material. However, failure of this technique may result from mechanical irritation of the capped nerve. In addition, the physical act of blocking the nerve end is insufficient to prevent further neuroma formation and additional measures need to be taken to halt the regenerative process of the nerve. A new technique of using a bioresorbable polycaprolactone cap (NEUROCAP®), leaving a chamber distal to the nerve ending, has been studied in animal models. The chamber results in a resultant thinner, cone shaped neuroma with a more organised fascicle structure. The chamber prevents mechanical tether or compression by scar. The cap resorbs, preventing mechanical irritation of the nerve ending. We present a case where a NEUROCAP® was excised 6 months after implantation and the nerve end was studied. This study is the first of its kind, analysed in a human model.

Analysis of an End Neuroma 6 Months after Capping with a Bioresorbable Polycaprolactone Cap (NEUROCAP®) in a Human Model